ARTICLE | Clinical News
Alista alprostadil: VVUS began a double-blind, placebo-controlled U.S. Phase II/III trial in women with sexual dysfunction.
April 1, 2002 8:00 AM UTC
Vivus Inc. (VVUS), Mountain View, Calif. Product: Alista alprostadil Business: Reproductive Therapeutic category: Vasodilation Target: Smooth muscle cells Description: Topical formulation of alprostad...